Using genetic, functional, and pharmacologic inhibition, we have demonstrated that dual inhibition of STAT3 and MEK signaling pathways significantly reduced viability of pancreatic and colon cancer cells. This evidence concerns the gene STAT3 and malignant colon neoplasm.